Lawyers and Settlements
What are you looking for?
Home Page >> Potential Lawsuit >> Lipozene Faces False Advertising Claims over Lipozene Weight Loss

Lipozene Faces False Advertising Claims over Lipozene Weight Loss Products

Washington, DC: The Obesity Research Institute has come under scrutiny for potential consumer fraud regarding claims of the effectiveness of its “Lipozene” products, specifically that the products are “safe and effective” weight loss products “clinically proven to reduce body fat.”

The controversy stems from allegedly fraudulent and misleading claims that the main ingredient in Lipozene, which is a water-soluble dietary fiber called Glucomannan, causes weight loss or reduction in body fat. Reportedly, one recently filed lawsuit cites several studies that showed Glucomannan was no more effective than placebo in reducing weight. And, that in order for any kind of substantial weight loss to occur, a person would have to take between 20 and 30 grams of Glucomannan per day, an amount which could cause severe diarrhea and other related gastrointestinal side effects.

Legal Help

If you or a loved one has suffered illness, adverse health effects or damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.

Last updated on Feb-1-12
LEGAL HELP NOW!
Please complete this form to request a review of your complaint by an attorney.

First name:

Last name:

Email address:

Phone number(s):

State:

Zip Code:

Defendant:

Describe your complaint:

Subscribe to our free newsletter


There is absolutely no cost to you to submit this form. Doing so places you under no obligations and does not establish an attorney-client relationship.

Related Lawsuits

Legal Services:

Facebook





Better Business Bureau

CAALA

Best of the Web Approved

Public Justice
 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map

This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2012 Online Legal Media. All rights reserved.